Center-Authored Papers

Filters: Keyword is HIV  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Zambia
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Young Adult
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A et al..  2010.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.. Journal of acquired immune deficiency syndromes (1999). 53(5):606-13. Abstract
Virus Replication
Migueles SA, Rood JE, Berkley AM, Guo T, Mendoza D, Patamawenu A, Hallahan CW, Cogliano NA, Frahm N, Duerr A et al..  2011.  Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.. PLoS pathogens. 7(2):e1002002. Abstract
OhAinle M, Kerns JA, Li MMH, Malik HS, Emerman M.  2008.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.. Cell host & microbe. 4(3):249-59. Abstract
Virion
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu S-lok, Stamatatos L.  2008.  Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.. Journal of virology. 82(12):5912-21. Abstract
Vaccine and Infectious Disease Institute
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin H-S, Brooks SF, Knight HL, Eichbaum Q et al..  2009.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.. Journal of virology. 83(14):7305-21. Abstract
Hudgens MG, Gilbert PB.  2009.  Assessing vaccine effects in repeated low-dose challenge experiments.. Biometrics. 65(4):1223-32. Abstract
Vaccine and Infectious Disease Division
Migueles SA, Rood JE, Berkley AM, Guo T, Mendoza D, Patamawenu A, Hallahan CW, Cogliano NA, Frahm N, Duerr A et al..  2011.  Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.. PLoS pathogens. 7(2):e1002002. Abstract
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell SR et al..  2011.  HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.. Blood. 117(20):5391-402. Abstract
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A et al..  2010.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.. Journal of acquired immune deficiency syndromes (1999). 53(5):606-13. Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Qureshi H, Ma Z-M, Huang Y, Hodge G, Thomas MA, Dipasquale J, Desilva V, Fritts L, Bett AJ, Casimiro DR et al..  2012.  Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine.. Journal of virology. 86(4):2239-50. Abstract
Uganda
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Treatment Outcome
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Transplantation, Autologous
Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell SR et al..  2011.  HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.. Blood. 117(20):5391-402. Abstract
Transfection
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu S-lok, Stamatatos L.  2008.  Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.. Journal of virology. 82(12):5912-21. Abstract
Garcia JV, Miller AD.  1991.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.. Nature. 350(6318):508-11. Abstract
Time Factors
Hudgens MG, Gilbert PB.  2009.  Assessing vaccine effects in repeated low-dose challenge experiments.. Biometrics. 65(4):1223-32. Abstract
Tetradecanoylphorbol Acetate
Garcia JV, Miller AD.  1991.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.. Nature. 350(6318):508-11. Abstract
Tanzania
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
T-Lymphocytes, Cytotoxic
Migueles SA, Rood JE, Berkley AM, Guo T, Mendoza D, Patamawenu A, Hallahan CW, Cogliano NA, Frahm N, Duerr A et al..  2011.  Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.. PLoS pathogens. 7(2):e1002002. Abstract
T-Lymphocytes
Garcia JV, Miller AD.  1991.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.. Nature. 350(6318):508-11. Abstract
Survival Analysis
Hudgens MG, Gilbert PB.  2009.  Assessing vaccine effects in repeated low-dose challenge experiments.. Biometrics. 65(4):1223-32. Abstract